Don’t forget you can visit MyAlerts to manage your alerts at any time.
Transparency rules for funders in tort mass cases, and how funding affects the "business model" of plaintiff mass tort litigaiton
By Max Mitchell | November 27, 2017
A lead attorney in the NFL concussion settlement has been very critical of numerous third-party litigation funding companies that have loaned money to retired players involved in the class action, but it is his alleged failure to publicly disclose his history with another litigation funding company that has raised some eyebrows recently.
1 minute read
By Jenna Greene | November 19, 2017
In the first bellwether trial in California over the anti-psychotic Risperdal, it took a Los Angeles Superior Court jury less than two hours to find for the drugmakers. What did lead lawyer Daniel Petrocelli say to them at closing?
1 minute read
By Catherine Wilson | November 17, 2017
The Daily Business Review recognizes the legal accomplishments of dozens of South Florida attorneys with its Most Effective Lawyers awards.
1 minute read
By Max Mitchell | November 17, 2017
Lawyers representing plaintiffs in three separate cases against Johnson & Johnson subsidiaries have alleged over the past six weeks that attorneys for the health care products company have engaged in improper contact with witnesses in the cases.
1 minute read
By Max Mitchell | November 14, 2017
The Pennsylvania Superior Court has reversed Janssen Pharmaceuticals' only defense verdict in the Risperdal mass tort litigation in Philadelphia.
1 minute read
By Max Mitchell | November 6, 2017
The label for the blood thinner Xarelto was front and center during opening statements Monday in the first trial over the stroke-prevention medication.
1 minute read
By Amanda Bronstad | November 6, 2017
A Georgia-Pacific LLC unit is blaming “abuses in the tort system” for the skyrocketing number of lawsuits that forced it to file for Chapter 11…
1 minute read
By Max Mitchell | November 6, 2017
The start of the first Xarelto trial in Philadelphia was sidelined Monday morning by a motion alleging that a Janssen Pharmaceutical sales representative may have influenced the testimony of a key witness in the case.
1 minute read
By Max Mitchell | November 2, 2017
The first case from the Xarelto mass tort in Philadelphia is set to begin soon, and attorneys are paying special attention to the plaintiffs' first try in state court.
1 minute read
By Cogan Schneier | October 24, 2017
The U.S. Chamber of Commerce says there's a lack of oversight for drug and medical device lawsuit advertising that must be addressed.
1 minute read
Presented by BigVoodoo
The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania and Delaware.
Consulting Magazine recognizes leaders in technology across three categories Leadership, Client Service and Innovation.
Celebrate outstanding achievement in law firms, chambers, in-house legal departments and alternative business structures.
Truly exceptional Bergen County New Jersey Law Firm is growing and seeks strong plaintiff's personal injury Attorney with 5-7 years plaintif...
Epstein Becker & Green is seeking an associate to joins its Commercial Litigation practice in our Columbus or Cincinnati offices. Ca...
McCarter & English, LLP, a well established and growing law firm, is actively seeking a talented and driven associate having 2-5 years o...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS